Ebos on target to meet forecast earnings in first half

Ebos on target to meet forecast earnings in first half
By Paul McBeth Oct. 23 (BusinessDesk) - Ebos Group, the healthcare and animal care products company, is on target to meet its forecast earnings in the first half as its $1.1 billion acquisition of Australian pharmaceuticals firm Symbion gives it greater scale across the Tasman. The Christchurch-based company expects to meet its forecast net profit of $48.7 million on revenue of $3.17 billion in the six months ending Dec. 31, having finished the first quarter, according to presentation slides accompanying managing director Mark Waller’s spee...